DNAP unlocking DNA coding Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : DNAP unlocking DNA coding

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Evan who wrote (24)	8/30/2000 6:01:37 PM
From: Evan	Read Replies (1) of 95

From RB : Well, a genome stock for $0.121, I think this speaks for itself. Most investors have obviously not heard of this company but, in my opinion, that should change in the upcoming months and by then these prices could be history. DNAP is also one of only five emerging companies that has been invited to present at the 8th Annual BioPartnering Europe (BPE) conference held in London October 16-17th. The conference is the premier European venue for showcasing innovative biophamaceutical and diagnostics companies from Europe, North America, Japan and the rest of the world. To think a company of this stature is going to go unnoticed for much longer is ludicrous. Plainly stated, the future for this gem looks truly fascinating. Target Price: 3-6 Month Target Price = $1 - $3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next